Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Edwards

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Antiviral Research|March 20, 2019
Retraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192]Nataliia V Petrova, Alexandra G Emelyanova, Evgeniy A Gorbunov, et al.
American Journal of Respiratory and Critical Care Medicine|October 5, 2010
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbationPatrick Mallia, Simon D Message, Vera Gielen, et al.
Plos Pathogens|September 2, 2017
Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airwaysAnn-Kathrin Reuschl, Michael R Edwards, Robert Parker, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epitheliumJames D Porter, Jennifer Watson, Lee R Roberts, et al.
Antiviral Research|March 31, 2017
Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo resultsNataliia V Petrova, Alexandra G Emelyanova, Evgeniy A Gorbunov, et al.
JCI Insight|April 8, 2021
miR-122 promotes virus-induced lung disease by targeting SOCS1Adam M Collison, Leon A Sokulsky, Elizabeth Kepreotes, et al.
The Journal of Infectious Diseases|December 15, 2010
RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activityAurica G Telcian, Vasile Laza-Stanca, Michael R Edwards, et al.
American Journal of Respiratory and Critical Care Medicine|January 14, 2017
Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to AeroallergensJaideep Dhariwal, Aoife Cameron, Maria-Belen Trujillo-Torralbo, et al.
Thorax|October 30, 2021
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trialHugo Farne, Nicholas Glanville, Nicholas Johnson, et al.
Nature Medicine|November 9, 2017
Corrigendum: Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbationMarie Toussaint, David J Jackson, Dawid Swieboda, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Antiviral Research|March 20, 2019
Retraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192]Nataliia V Petrova, Alexandra G Emelyanova, Evgeniy A Gorbunov, et al.
American Journal of Respiratory and Critical Care Medicine|October 5, 2010
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbationPatrick Mallia, Simon D Message, Vera Gielen, et al.
Plos Pathogens|September 2, 2017
Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airwaysAnn-Kathrin Reuschl, Michael R Edwards, Robert Parker, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epitheliumJames D Porter, Jennifer Watson, Lee R Roberts, et al.
Antiviral Research|March 31, 2017
Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo resultsNataliia V Petrova, Alexandra G Emelyanova, Evgeniy A Gorbunov, et al.
JCI Insight|April 8, 2021
miR-122 promotes virus-induced lung disease by targeting SOCS1Adam M Collison, Leon A Sokulsky, Elizabeth Kepreotes, et al.
The Journal of Infectious Diseases|December 15, 2010
RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activityAurica G Telcian, Vasile Laza-Stanca, Michael R Edwards, et al.
American Journal of Respiratory and Critical Care Medicine|January 14, 2017
Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to AeroallergensJaideep Dhariwal, Aoife Cameron, Maria-Belen Trujillo-Torralbo, et al.
Thorax|October 30, 2021
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trialHugo Farne, Nicholas Glanville, Nicholas Johnson, et al.
Nature Medicine|November 9, 2017
Corrigendum: Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbationMarie Toussaint, David J Jackson, Dawid Swieboda, et al.
Pageof 13